# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-19-002206
Filing Date
2019-07-16
Accepted
2019-07-16 13:23:27
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDMENT NO. 1 TO FORM S-1 | cns_s1a1.htm | S-1/A | 1099206
2 | FORM OF UNDERWRITING AGREEMENT | cns_ex0101.htm | EX-1.1 | 251003
3 | FORM OF UNDERWRITERS WARRANT AGREEMENT | cns_ex0404.htm | EX-4.4 | 89292
4 | OPINION | cns_ex0501.htm | EX-5.1 | 18586
5 | EMPLOYMENT LETTER | cns_ex1008.htm | EX-10.8 | 21811
6 | EMPLOYMENT LETTER | cns_ex1009.htm | EX-10.9 | 21962
7 |  | cns_ex2301.htm | EX-23.1 | 2418
8 | GRAPHIC | loev_logo.jpg | GRAPHIC | 571435
9 | GRAPHIC | malonelogo.jpg | GRAPHIC | 27582
| Complete submission text file | 0001683168-19-002206.txt |  | 2330152

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-232443 | Film No.: 19956771
SIC: 2834 Pharmaceutical Preparations